Contemporary adhesion prevention.
OBJECTIVE
To (1) review the events leading to peritoneal adhesion formation; (2) review traditional adhesion prevention adjuvants; (3) overview studies for adhesion prevention barriers including a perspective for their use; and (4) look toward the future of adhesion prevention.


RESULTS
A great deal of effort has been dedicated to reduce adhesion formation because of the morbidity associated with adhesions and the associated economic burden, which considering only hospital costs and surgeons' fees, was $1,180 million in the United States. To understand the role of adhesion barriers in gynecological surgery, an appreciation of the cellular cascade and temporal nature of peritoneal repair is necessary. Evidence indicates that areas denuded of peritoneum will heal satisfactorily and that suturing of the peritoneum may increase adhesion formation. Physical barriers, including both mechanical and viscous solutions, are widely used to prevent adhesion formation by limiting tissue apposition during the critical stages of mesothelial repair. Clinical studies do not support the use of intraperitoneal, dextran for adhesion prevention. Theoretical considerations of peritoneal fluid dynamics indicate that crystalloid instillates should not prevent adhesion formation because of their short intraperitoneal residence. This prediction is consistent with clinical observation. The availability of Interceed (Johnson and Johnson Medical, Inc., Arlington, TX) and Gore-Tex Surgical Membrane (W.L. Gore, Flagstaff, Arizona) barriers provides substantial progress in postsurgical adhesion prevention.


CONCLUSIONS
Although many investigators are incorporating adhesion prevention barriers into their routine clinical situations, physician acceptance is constrained by technical difficulties.
diZerega
G S
GS
Livingston Reproductive Biology Laboratory, Department of Obstetrics and Gynecology, University of Southern California School of Medicine, Los Angeles.
D000818:Animals; D002482:Cellulose; D005260:Female; D005836:Genitalia, Female / Q000601:surgery; D006801:Humans; D007249:Inflammation / Q000503:physiopathology; D008567:Membranes, Artificial; D010537:Peritoneum / Q000503:physiopathology; D011138:Polytetrafluoroethylene; D012996:Solutions; D000267:Tissue Adhesions / Q000517:prevention & control*; D014945:Wound Healing
D008567:Membranes, Artificial; D012996:Solutions; D011138:Polytetrafluoroethylene; D002482:Cellulose